| BADL performance | IADL performance | ||||
---|---|---|---|---|---|---|
PRO measure | Deteriorated (n = 397) | Not deteriorated (n = 160) | p-value | Deteriorated (n = 418) | Not deteriorated (n = 139) | p-value |
WOMAC: LCF | Â | Â | Â | Â | Â | Â |
Baseline | 41.4 (27.5) | 14.8 (18.6) | <0.0001 | 39.4 (28.1) | 16.9 (19.7) | <0.0001 |
Pre-Post | -30.2 (25.6) | -16.5 (23.2) | <0.0001 | -30.7 (25.0) | -13.0 (23.0) | <0.0001 |
WOMAC: Pain | Â | Â | Â | Â | Â | Â |
Baseline | 14.5 (21.8) | 7.9 (15.5) | <0.0001 | 14.2 (21.6) | 7.7 (15.5) | 0.0001 |
Pre-Post | -13.5 (33.7) | -7.4 (22.2) | 0.015 | -13.0 (33.2) | -7.9 (22.5) | 0.047 |
SF-12 PCS | Â | Â | Â | Â | Â | Â |
Baseline | 37.3 (10.3) | 46.2 (9.6) | <0.0001 | 38.1 (10.6) | 45.0 (10.0) | <0.0001 |
Post-Pre | -9.2 (11.6) | -9.2 (10.6) | 0.996 | -9.8 (11.5) | -7.8 (10.5) | 0.101 |
SF-12 MCS | Â | Â | Â | Â | Â | Â |
Baseline | 49.8 (11.8) | 52.9 (9.7) | 0.002 | 49.7 (11.8) | 53.7 (9.3) | 0.0003 |
Post-Pre | -4.8 (14.6) | -1.3 (12.2) | 0.010 | -4.3 (14.4) | -2.1 (12.8) | 0.148 |
Barthel | Â | Â | Â | Â | Â | Â |
Baseline | 81.9 (23.5) | 98.1 (5.1) | <0.0001 | 82.6 (23.2) | 98.3 (4.5) | <0.0001 |
Post-Pre | -33.1 (-23.9) | -0.1 (4.8) | - | -30.3 (25.3) | -3.7 (9.4) | <0.0001 |
Lawton | Â | Â | Â | Â | Â | Â |
Baseline | 4.0 (2.9) | 6.9 (1.8) | <0.0001 | 4.0 (2.9) | 7.1 (1.4) | <0.0001 |
Post-Pre | -2.0 (2.3) | -0.6 (1.6) | <0.0001 | -2.2 (2.1) | 0.1 (1.1) | - |